Exelixis Inc Public Float
Exelixis Inc (EXEL) had Public Float of $9.40 billion as of 2025-07-04, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-10
- 2025-07-04: Entity Public Float $9.40B.
- 2024-06-28: Entity Public Float $4.80B.
- 2023-06-30: Entity Public Float $4.70B.
- 2022-07-01: Entity Public Float $6.83B.
| Period end | Entity Public Float |
|---|---|
| 2025-07-04 | $9.40B 10-K · filed 2026-02-10 |
| 2024-06-28 | $4.80B 10-K · filed 2025-02-11 |
| 2023-06-30 | $4.70B 10-K · filed 2024-02-06 |
| 2022-07-01 | $6.83B 10-K · filed 2023-02-07 |
| 2021-07-02 | $5.68B 10-K · filed 2022-02-18 |
| 2020-07-03 | $6.40B 10-K · filed 2021-02-11 |
| 2019-06-28 | $5.73B 10-K · filed 2020-02-25 |
| 2018-06-29 | $5.53B 10-K · filed 2019-02-22 |
| 2017-06-30 | $7.12B 10-K · filed 2018-02-26 |
| 2016-07-01 | $1.36B 10-K · filed 2017-02-27 |
| 2015-06-30 | $663.21M 10-K · filed 2016-02-29 |
| 2014-06-27 | $665.61M 10-K · filed 2015-03-02 |
| 2013-06-30 | $820.78M 10-K · filed 2014-02-20 |
| 2012-06-29 | $805.02M 10-K · filed 2013-02-21 |
| 2011-06-30 | $1.15B 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |